Method of treating diabetes type 2 by administering ultrarapid acting insulin
US8623817B2 · kind B2 · utility
0Cited by
89References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 17, 2012 |
| Grant date | Jan 7, 2014 |
| Priority date | — |
| Expiry date | Feb 24, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.